Qiagen: Stephen Rusckowski, Lawrence Rosen

Qiagen said this week that its supervisory board intends to elect Stephen Rusckowski to succeed Lawrence Rosen as chairman of the board following its annual general meeting on June 26. Qiagen said Rosen has decided to step down as chairman and as a board member after the meeting. He has served on the board since 2013 and has held the role of chairman since August 2020.

Rusckowski joined the board in 2023 and currently serves as chair of the nomination and governance committee. He most recently held the position of chairman, president, and CEO of Quest Diagnostics. Prior to that he was CEO of Philips Healthcare.